INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,498,649 Value ($000) $9,995 Avg Close — Range —
Q1 2025
Shares 2,758,478 Value ($000) $2,510 Avg Close — Range —
Q4 2024
Shares 2,633,249 Value ($000) $7,294 Avg Close — Range —
Q3 2024
Shares 2,624,338 Value ($000) $13,725 Avg Close — Range —
Q2 2024
Shares 2,629,309 Value ($000) $11,727 Avg Close — Range —
Q1 2024
Shares 2,419,020 Value ($000) $18,530 Avg Close — Range —
Q4 2023
Shares 2,385,022 Value ($000) $10,160 Avg Close — Range —
Q3 2023
Shares 2,276,085 Value ($000) $9,560 Avg Close — Range —
Q2 2023
Shares 1,395,910 Value ($000) $7,775 Avg Close — Range —
Q1 2023
Shares 1,328,290 Value ($000) $7,611 Avg Close — Range —
Q4 2022
Shares 1,343,622 Value ($000) $1,411 Avg Close — Range —
Q3 2022
Shares 1,343,063 Value ($000) $3,599 Avg Close — Range —
Q2 2022
Shares 1,354,216 Value ($000) $6,460 Avg Close — Range —
Q1 2022
Shares 489,613 Value ($000) $2,003 Avg Close — Range —
Q4 2021
Shares 488,719 Value ($000) $3,333 Avg Close — Range —
Q3 2021
Shares 611,185 Value ($000) $7,084 Avg Close — Range —
Q2 2021
Shares 335,286 Value ($000) $5,713 Avg Close — Range —
Q1 2021
Shares 340,964 Value ($000) $6,751 Avg Close — Range —
Q4 2020
Shares 309,114 Value ($000) $6,380 Avg Close — Range —
Q3 2020
Shares 297,037 Value ($000) $7,809 Avg Close — Range —